Nurea develops the PRAEVAorta® 2 software, a class IIb medical device that utilizes AI for automated segmentation and geometric analysis of the aorta, enabling precise quantification of vascular diseases. This technology facilitates faster and more secure diagnosis and surgical planning, improving patient outcomes in vascular healthcare.
Funding
$3.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Vascular diseases, such as aneurysms, require precise quantification for accurate diagnosis, surgical planning, and follow-up. Manual segmentation and geometric analysis of the aorta from medical images are time-consuming and prone to inter-observer variability. This can lead to delays in diagnosis and suboptimal surgical planning.
Solution
Nurea's PRAEVAorta® 2 software is a class IIb medical device that leverages artificial intelligence to automate the segmentation and geometric analysis of the aorta from medical images. The software provides rapid visualization of the aorta's status through geometrical data, enabling faster and more secure diagnoses. It delivers automated surgery planning data for EVAR/FEVAR planification and offers infrarenal diameter and volume measurements for patient follow-up. PRAEVAorta® 2 enhances vascular physicians’ productivity and aids in aortic disease prevention by providing a "0 click" solution for vascular disease quantification.
Target Audience
The primary users are vascular surgeons, radiologists, and clinical researchers involved in the diagnosis, treatment, and monitoring of aortic and vascular diseases.
Features
- AI-powered automated segmentation of the aorta from medical images
- Geometric analysis providing key measurements such as aorta maximum diameter, infrarenal diameter, and volume
- Automated surgery planning data for EVAR/FEVAR procedures
- 3D numerical simulations for biomedical modeling
- Streamlined workflow with rapid visualization of aortic status
- Decision-making support for diagnosis and follow-up of vascular diseases